Clinical Trial

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
This single-arm study is designed to test the hypothesis that a six-month intermittent fasting (IF) intervention is feasible for patients to adhere to and improves health-related quality of life while subjects are on adjuvant endocrine therapy (AET).
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-07-15 -> 2027-07-15 2026-08-06
minor Completion pushed: 2026-07-15 -> 2027-07-15 2026-08-06
Trial Details
NCT Number NCT06106477
Lead Sponsor Medical College of Wisconsin
Conditions Breast Cancer
Enrollment 20 participants
Start Date 2024-07-19
Primary Completion 2027-07-15 (estimated)
Study Completion 2027-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-08-05